Key result
This review details and compares the assembly and the DNA/RNA targeting mechanisms of the various surveillance complexes of prokaryotic CRISPR-Cas immune systems.
This review provides comprehensive insights into the assembly and DNA/RNA targeting mechanisms of various prokaryotic CRISPR-Cas immune systems.
Comparative CRISPR-Cas analysis in prokaryotes; leaves open eukaryotic translation and cardiovascular gene-editing applications.
The CRISPR (clustered regularly interspaced short palindromic repeats)-Cas (CRISPR-associated) adaptive immune systems use small guide RNAs, the CRISPR RNAs (crRNAs), to mark foreign genetic material, e.g. viral nucleic acids, for degradation. Archaea and bacteria encode a large variety of Cas proteins that bind crRNA molecules and build active ribonucleoprotein surveillance complexes. The evolution of CRISPR-Cas systems has resulted in a diversification of cas genes and a classification of the systems into three types and additional subtypes characterized by distinct surveillance and interfering complexes. Recent crystallographic and biochemical advances have revealed detailed insights into the assembly and DNA/RNA targeting mechanisms of the various complexes. Here, we review our knowledge on the molecular mechanism involved in the DNA and RNA interference stages of type I (Cascade: CRISPR-associated complex for antiviral defense), type II (Cas9) and type III (Csm, Cmr) CRISPR-Cas systems. We further highlight recently reported structural and mechanistic themes shared among these systems.
No takes yet. Share an insight, caveat, or question.
Plagens et al. (2015) conducted a review in CRISPR-Cas immune systems. CRISPR-Cas surveillance complexes was evaluated. This review details and compares the assembly and the DNA/RNA targeting mechanisms of the various surveillance complexes of prokaryotic CRISPR-Cas immune systems.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: